Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated Steatohepatitis
The Journal of Immunology · 01.08.2024 · 213 (3) · 251-256
DOI: 10.4049/jimmunol.2300847 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 05.06.2024. Verfasst von Mandy M Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Macrophages, Liver Cirrhosis, Phenotype. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM), NIDDK NIH HHS.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by infiltration of monocyte-derived macrophages (MdMs) into the liver; however, the function of these macrophages is largely unknown. We previously demonstrated that a population of MdMs, referred to as hepatic lipid-associated macrophages (LAMs), assemble into aggregates termed hepatic crown-like structures in areas of liver fibrosis. Intriguingly, decreasing MdM recruitment resulted in increased liver fibrosis, suggesting that LAMs contribute to antifibrotic pathways in MASH. In this study, we determined that hepatic crown-like structures are characterized by intimate interactions between activated hepatic stellate cells (HSCs) and macrophages in a collagen matrix in a mouse model of MASH. MASH macrophages displayed collagen-degrading capacities, and HSCs derived from MASH livers promoted expression of LAM marker genes and acquisition of a collagen-degrading phenotype in naive macrophages. These data suggest that crosstalk between HSCs and macrophages may contribute to collagen degradation MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
ORCID-Profile: Mandy M Chan, Brian N Finck, Joel D Schilling, Sabine Daemen
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- NIDDK NIH HHS
Zitieren
APA
Chan, M. M., He, L., Finck, B. N., Schilling, J. D., & Daemen, S. (2024). Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated Steatohepatitis. The Journal of Immunology, 213(3), 251-256. https://doi.org/10.4049/jimmunol.2300847
Vancouver
Chan MM, He L, Finck BN, Schilling JD, Daemen S. Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated Steatohepatitis. The Journal of Immunology. 2024;213(3):251-256. doi:10.4049/jimmunol.2300847
BibTeX
@article{Chan2024,
author = {Chan, Mandy M and He, Li and Finck, Brian N and Schilling, Joel D and Daemen, Sabine},
title = {Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated Steatohepatitis},
journal = {The Journal of Immunology},
year = {2024},
volume = {213},
number = {3},
pages = {251--256},
doi = {10.4049/jimmunol.2300847}
}
EUVIMED